Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 4.
| Dosage form | NDCs |
|---|---|
| liquid | 3 |
| gas | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| curium netherlands b.v. | 4 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Gallium (Ga-67) Chloride | liquid | 63518-3104DRUG FOR FURTHER PROCESSING |
| - | Sodium Molybdate | liquid | 63518-4200DRUG FOR FURTHER PROCESSING |
| - | Sodium Molybdate | liquid | 63518-4250DRUG FOR FURTHER PROCESSING |
| - | xenon | gas | 63518-5450DRUG FOR FURTHER PROCESSING |
Enquiry
Common questions
- Is Curium Netherlands B.V. FDA approved?
- Curium Netherlands B.V. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Curium Netherlands B.V. make?
- 4 products are listed under Curium Netherlands B.V. in the openFDA NDC Directory, most often as liquid; gas. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.